Organisation paid for research Program year 2025 Source: CMS Open Payments

Sneeze Wheeze Itch Associates

Neither a doctor nor a teaching hospital

Research payments

$343,530

53 payments

Through program year 2025, Sneeze Wheeze Itch Associates is reported as receiving $343,530 in research payments, across 53 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$95,817	19
2024	Research	$228,418	30
2022	Research	$6,369	2
2021	Research	$12,926	2

Breakdown

Who paid Research payments · program years 2021–2025

GlaxoSmithKline, LLC. $297,079 45 payments
Sanofi US Services Inc. $46,451 8 payments

Studies the money was for Research payments · program years 2021–2025

A Phase 3, 52-Week, Randomized, Double-Blind, Placebo-Controlled, Para $226,835 33 payments
An Open-Label Multinational, Multicenter Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Atopic Dermatitis $46,451 8 payments
A Multi-Centre, Single Arm, Open-Label Extension Study to Evaluate the $41,099 6 payments
A Randomized, Adaptive, Double-Blind, Placebo-Controlled, Parallel-Arm $19,295 4 payments
A 52-Week, Randomised, Double-Blind, Placebo-Controlled, Parallel-Grou $8,100 1 payment
A Phase 3, 24-Week, Randomized, Double-Blind, Parallel-Group Bayesian $1,750 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.